Understanding the Impact of Reperfusion in the Development of a Safe Compression Therapy
July 2025
in “
Microscopy and Microanalysis
”
TLDR Intermittent compression therapy is safe and doesn't harm tissue.
The study developed a model using C57BL/6 male mice to test the safety and efficacy of compression therapy, focusing on minimizing injury. The modified ischemia/reperfusion protocol involved using magnets to apply pressure, which increased epidermal thickness and altered blood vessel density without causing significant DNA damage or changes in stem cell populations. Hair growth was initially stunted but resumed within 18 days. The protocol showed no visual signs of pressure ulcer formation and maintained hair growth potential, suggesting that increased vascularization could enhance hair growth. This model provides a basis for developing safer compression therapies, particularly concerning hair follicles.
